Skip to main content
. 2021 Jan 17;34(2):634–643. doi: 10.1007/s13577-020-00483-y

Fig. 3.

Fig. 3

Similar to Fig. 2, but for administration of KRB solution containing 200 μM of 2-NBDLG and 20 μM of 2-TRLG